N-[3-({2-[1-(2-anilino-2-oxoethyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]hydrazino}carbonyl)phenyl]benzamide manufacturers
- AG6033
-
- $1520.00
-
2026-04-21
- CAS:329706-62-9
- Purity:
- Supply Ability: 10g
|
| | N-[3-({2-[1-(2-anilino-2-oxoethyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]hydrazino}carbonyl)phenyl]benzamide Basic information |
| | N-[3-({2-[1-(2-anilino-2-oxoethyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]hydrazino}carbonyl)phenyl]benzamide Chemical Properties |
| density | 1.32±0.1 g/cm3(Predicted) | | pka | 10.23±0.20(Predicted) |
| | N-[3-({2-[1-(2-anilino-2-oxoethyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]hydrazino}carbonyl)phenyl]benzamide Usage And Synthesis |
| Uses | AG6033 is a potential novel CRBN modulator. AG6033 suppresses various tumor cells by modulating the interactions between CRBN and various antitumor target proteins. AG6033 can cause GSPT1 and IKZF1 degradation. AG6033 induces CRBN-dependent cytotoxic effect[1]. | | IC 50 | CRBN | | References | [1] Xiong F, Kong L, Chen L, et al. Discovery of potential novel CRBN modulators by virtual screening and bioassay. Eur J Med Chem. 2022 Apr 5;236:114355. DOI:10.1016/j.ejmech.2022.114355 |
| | N-[3-({2-[1-(2-anilino-2-oxoethyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]hydrazino}carbonyl)phenyl]benzamide Preparation Products And Raw materials |
|